WESTLOCK PARTNERS LIMITED

Executive Summary

WESTLOCK PARTNERS LIMITED is financially healthy with strong liquidity and positive working capital, reflecting sound early-stage business stability. The company is well-capitalized and compliant with regulatory filings, though limited operational history warrants careful monitoring and focus on building profitability. Strategic investments and robust governance will support sustainable growth and long-term financial wellness.

WESTLOCK PARTNERS LIMITED - Analysis Report

Company Number: 15087257

Analysis Date: 2025-07-29 20:16 UTC

Financial Health Assessment Report for WESTLOCK PARTNERS LIMITED

---

1. Financial Health Score: B+

Explanation:
WESTLOCK PARTNERS LIMITED demonstrates a strong foundation with a healthy net asset position, positive working capital, and no overdue filings. Being a newly incorporated company (August 2023) with a clean balance sheet and adequate cash reserves, it shows promising early-stage financial health. The score reflects solid liquidity and equity but recognizes limited operational history and small asset base, suggesting room for growth and monitoring.

---

2. Key Vital Signs

Metric	Value (£) / Status	Interpretation (Medical Analogy)
Fixed Assets	£2,745	Minimal "structural assets," normal for a new consultancy firm. No signs of over-investment.
Current Assets (Cash)	£44,553	"Healthy blood flow" of cash available to meet immediate needs. Strong liquidity.
Current Liabilities	£1,919	"Short-term obligations" are low and manageable relative to cash.
Net Current Assets	£42,634	Positive "working capital," indicating good short-term financial health.
Total Net Assets	£45,379	Solid "body mass" of equity, shows company is funded primarily by shareholders.
Share Capital	£100	Nominal "seed capital," majority of equity is retained earnings or reserves.
Filing Status	Up to date	No "symptoms" of regulatory distress or non-compliance.
Directors	1 active, 1 resigned	Director changes are common in startups; no disqualifications noted.
Company Age	~1 year	Early stage, still in "growth phase" with limited financial history.

---

3. Diagnosis

Summary of Financial Condition:
WESTLOCK PARTNERS LIMITED is in a healthy financial state for its infancy. The company exhibits "healthy cash flow" with £44.5k in cash and minimal liabilities, which translates into strong liquidity and the ability to meet short-term obligations comfortably. The net assets of £45.4k, mainly equity, indicate the company is well-capitalized relative to its current scale.

The small level of fixed assets (£2.7k) is typical for a management consultancy, which tends to be asset-light and relies on intellectual capital rather than physical assets. Positive net current assets (working capital) suggest the company can fund operational needs without external liquidity pressure.

The absence of overdue filings or signs of financial distress is reassuring, and the director structure is stable with no misconduct records. However, being newly incorporated, the company’s financial "immune system" is still developing—there is limited operational history and no detailed profit & loss data available, which means forecasting future performance carries inherent uncertainty.

---

4. Recommendations

To strengthen the financial wellness and prepare for sustainable growth, the company should consider the following actions:

• Build Revenue and Profitability Data: Ensure accurate and timely recognition of turnover and expenses to develop a clear profitability picture. This will help detect early "symptoms" of business strain or opportunity.

• Maintain Strong Liquidity: Continue monitoring cash flow carefully. While current liquidity is healthy, management should avoid unnecessary cash burn to preserve the company’s "vital signs."

• Plan for Growth Investment: As a consultancy, investing in talent and technology will be key. Consider allocating resources prudently for scalable growth without overextending fixed assets.

• Governance and Compliance: Keep up-to-date with filing deadlines and statutory requirements to avoid regulatory "infections" such as penalties or reputational damage.

• Director Stability: Given one director resigned recently, ensure that governance remains robust with clear leadership roles to maintain strategic direction and accountability.

• Financial Forecasting and Scenario Planning: Develop forecasts and contingency plans to anticipate potential "health shocks" such as market downturns or client loss.

---

Executive Summary